Meta-Analysis: Drug Side Effect, Smoking, Alcohol Consumptions and Their Relationships with Drug Taking Adherence in Tuberkulosis Patients
DOI:
https://doi.org/10.26911/jepublichealth.2023.08.03.09Abstract
Background: Inappropriate tuberculosis treatment is a major determinant of multidrug-resistant tuberculosis (MDR) TB, which is related to patient adherence to treatment. There are several factors that affect MDR-TB such as drug side effects, smoking and alcohol consumption. The aim is to estimate the magnitude of the effect of drug side effects on tuberculosis treatment adherence, based on the results of a number of similar primary studies.
Subjects and Method: This study is a systematic review and meta-analysis research. Article search was carried out based on the eligibility criteria of the PICO model including: P= Tuberculosis patient; I= drug side effects, smoking and alcohol consumption; C= no drug side effects, no smoking and no alcohol consumption; O= Tuberculosis treatment adherence. Articles were collected from Google scholar, PubMed, Science Direct, and Springerlink. Keywords using “drug side effects” OR “tobacco smoking” OR “alcohol consumption” OR “tuberculosis” AND “medication adherence” AND “cross sectional” AND “adjusted odds ratio”. Inclusion criteria in this study included articles with a cross-sectional study design, the relationship size used was the adjusted Odds Ratio (aOR), articles published in the 2009 to 2022 range. Selected articles were tested for eligibility using CEBM and analyzed using the PRISMA diagram and the Review Manager 5.3 application.
Results: 14 Cross-sectional studies were selected for the meta-analysis of 8 studies with 2,045 TB patients showed that drug side effects reduced TB treatment adherence by 0.26 times than no drug side effects (aOR= 0.26; 95% CI= 0.14 to 0.49; p< 0.001). 7 studies with 2,966 TB patients showed that alcohol consumption decreased TB treatment adherence by 0.61 times than not consuming alcohol (aOR= 0.61; 95% CI= 0.32 to 1.16; p= 0.130). Study 6 with 1,748 TB patients showed that smoking decreased TB treatment adherence by 0.86 times than non-smokers (aOR= 0.86; 95% CI= 0.17 to 4.37; p= 0.850).
Conclusion: Side effects of drugs, alcohol, and smoking reduce treatment adherence in tuberculosis patients.
Keywords: drug side effects, alcohol consumption, smoking, treatment adherence
Correspondence: Aem Ismail. Master’s Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta, Central Java, Indonesia. Email: aem.ismail80@gmail.com. Mobile: +6282133114822.
References
Ajema D, Shibru T, Endalew T, Gebeyehu S (2020). Level of and associated factors for non-adherence to anti-tuberculosis treatment among tuberculosis patients in Gamo Gofa Zone, Southern Ethiopia. Cross-Sectional Study. BMC Public Health. 20(1): 1-9. doi: 10.1186/s12889-020-09827-7.
Amuha MG, Kutyabami P, Kitutu FE, Odoi-Adome R, Kalyango JN (2009). Non-adherence to anti-TB drugs among TB/HIV co-infected patients in Mbarara Hospital Uganda: prevalence and associated factors. African health sciences, 9(2): 8-15.
Bagchi S, Ambe G, Sathiakumar N (2010). Determinants of poor adherence to anti-tuberculosis treatment in Mumbai, India. Int J Prev Med. 1(4): 223-232.
Bereda G, Gemechis B (2021). Determinants of, and Factors Influencing Medication poor adherence to pulmonary tuberculosis treatment at the tuberculosis Clinic of Mettu Karl Referral Hospital, South-western, Ethiopia: A Prospective Cross Sectional Study, 2021. Arch pulmonol respir care. 1(1): 1-8.
Bello SI, Itiola OA (2010). Drug adherence amongst tuberculosis patients in the University of Ilorin Teaching Hospital, Ilorin, Nigeria. Afr J Pharm Pharmacol. 4(3): 109-114.
Chen X, Du L, Wu R, Xu J, Ji H, Zhang Y, Zhu X, et al. (2020). The effects of family, society and national policy support on treatment adherence among newly diagnosed tuberculosis patients: a cross-sectional study. BMC Infect Dis. 20(1): 2-11. doi: 10.1186/s12879-020-05354-3.
Cahyaningtyas DY, Perwiraningtyas P, Sulasmini S (2018). The relationship between side effects of anti-tuberculosis drugs (OAT) on tuberculosis (TB) patient compliance in tuberculosis (TB) treatment at Panti Waluyo Hospital Malang. Scientific J. Nurs. 3(2): 20-31.
Eticha T, Kassa E (2014). Non-adherence to anti-tb drugs and its predictors among tb/hiv coinfected patients in Mekelle, Ethiopia. J. Bioanal. Biomed. 6(6): 61-64. doi: 10.4172/1948-593X.1000113.
Gebreweld FH, Kifle MM, Gebremicheal FE, Gezae MM, Gebremicheal FE, Ghebre-yesus SS, Mengsteab YT, et al. (2018). Factors influencing adherence to tuberculosis treatment in asmara, eritrea: a qualitative study. J Health Popul Nutr. 37(1):1–9. doi: 10.1186/s41043-017-0132-y.
Gube AA, Debalkie M, Seid K, Bisete K, Mengesha A, Zeynu A, Shimelis F, et al. (2018). Assessment of anti-TB drug nonadherence and associated factors among tb patients attending tb clinics in arba minch govern-mental health institutions, Southern Ethiopia. Tuberc Res Treat. 6-7 doi: 10.1155/2018/37-05812.
Gloria CV, Rasyid ZWSV, Kursani E, Umayyah B (2019). Determinants of medication adherence in pulmonary tuberculosis patients. Kesmas Asclepius. 1(2): doi: 10.31539/jka.v1i2.919.
Ibrahim LM, Hadejia IS, Nguku P, Lakda GM, Ogiri S (2011). Factors Associated with Outcomes of Treatment among Pulmonary Tuberculosis Patients in Plateau State, Nigeria. J. Tradit. Chin. Med. Sci. 17(1): 172-179 doi: 10.172-65/15486648/2015.04.005.
Iweama CN, Agbaje OS, Umoke PCI, Igbok-we CC, Ozoemena EL, Omaka-Amari, NL, Idache BM (2021). Nonadherence to tuberculosis treatment and associated factors among patients using directly observed treatment short-course in northwest Nigeria: A cross-sectional study. SAGE Open Med. 9(1): 1-15. doi: 10.1177/2050312121989497.
Kiros, YK, Teklu T, Desalegn F, Tesfay M, Klinkenberg E, Mulugeta A (2014). Adherence to anti-tuberculosis treatment in Tigray, Northern Ethiopia. Pub Health A. 4(3): 32-36. doi: 10.5588/pha.14.0054.
Kisambu J, Nuwaha F, Sekandi JN (2014). Adherence to treatment and supervision for tuberculosis in a DOTS programme among pastoralists in Uganda. INT J Tuberc Lung Dis. 18(7): 802-803. doi: 10.5588/ijtld.13.0753.
Meda ZC, Lin YT, Sombie I, Mare D, Morisky DE, Chen YMA (2014). Medication-adherence predictors among patients with tuberculosis or human immunodeficiency virus infection in Burkina Faso. J Microbiol Immunol Infect. 47-(1): 222 - 2332. doi: 10.1016/j.jmii.2013.05.001.
Mekonnen HS, Azagew AW (2018). Non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia. BMC Res Notes. 11(1): 1-8. doi: 10.1186/s13104-018-3789-4.
Muna L, Soleha U (2018). Family motivation and social support affect adherence to treatment in pulmonary TB patients at the Bp4 Pamekasan pulmonary polyclinic. J. Health Sci. 7(2): 172-179. doi: 10.33086/jhs.v7i2.506.
Nortajulu B, Susianti, Hermawan D (2022) Factors associated with pulmonary TB recovery. J Prof Nurs 4(4): 1206-1216 doi: 10/37287/jppp.v4i4.1215.
Olys, Ardiyansah S (2018). Internal risk factors for treatment failure in patients with new intensive phase pulmonary tuberculosis). J Sains Farm Klin. 7 (1): 1-5. doi: 10.25077/jka.v7i1.783.
Rahmi N, Medison I, Suryadi I (2017). The relationship between the level of adherence of pulmonary tuberculosis patients with health behavior, OAT side effects and the role of PMO in the intensive phase of treatment at the Puskesmas Sebrang Padang in September 2012-2013. J Kesehatan Andalas. 6 (2): 345-350. doi: 10.25077/jka.v6i2.702.
RI Ministry of Health (2018). Ministry of Health of the Republic of Indonesia (2018) Caring for Healthy Indonesian TB. Health Information for Traveller To 2018.
Woimo TWK, Yimer T, Bati, Gesesew HA (2017). Prevalence and factors associated for anti-tuberculosis treatment non-adherence among pulmonary tuberculosis patients in public health care facilities in South Ethiopia. BMC Public Health. 17(1): 2-10 doi: 10.1186/s12-889-017-41889.
Wulandari DH (2015). Analysis of factors associated with adherence of advanced pulmonary tuberculosis patients to take medication at the integrated Rumah Sehat Hospital in 2015. ARSI. 2(1): 17-28. doi: 10.7454/arsi.v2i1.2186.
WHO (2020). Global Tuberculosis Report 2020. Geneva: World Health Organization.
WHO (2021). Global Tuberculosi Report 2021. Ganeva: World Health Organization.
